AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/ 2a Clinical Study of 177Lu-BetaBart

AtomVie Global Radiopharma Inc. Ontario New York

View original content:https://www.prnewswire.co.uk/news-releases/atomvie-global-radiopharma-supplies-first-patient-dose-in-radiopharm-theranostics-phase-12a-clinical-study-of-177lu-betabart-rv-01-302695311.html